top of page

COFEPRIS Technovigilance of medical devices in Mexico

COFEPRIS Technovigilance of medical devices in Mexico

In the dynamic landscape of healthcare, ensuring the safety and efficacy of medical devices is paramount. As technology continues to advance, so does the need for a robust regulatory framework that addresses potential risks and safeguards public health. In Mexico, the technovigilance of medical devices is a critical aspect of ensuring public health and safety. The current blog delves into the medical device incident reporting in Mexico, from understanding the criteria for reporting adverse events to exploring exceptions and deadlines.

Responsibilities of Health Registration Holders

The health registration holder or legal representative in Mexico bears the responsibility for implementing medical device vigilance reporting activities. This involves providing documentary evidence regarding the risk associated with the medical device, conducting risk analyses during development and post-marketing stages, and notifying the National Pharmacovigilance Center (CNFV) of adverse incidents.

Notification of Adverse Incidents: All adverse events must be documented and reported to the CNFV in writing. The principle of truthfulness in data reporting is emphasized, and the follow-up and final reports should be supported by documentary evidence.

Confidentiality and Quality Assurance: Confidentiality of user information is paramount, and all data, especially information not yet validated, must be treated with reservation. The medical device vigilance reporting units must ensure systems and procedures guarantee the quality of information processes.

Adherence to Regulatory Guidelines: The person responsible for evaluating adverse events must be qualified by education, training, and experience. Information related to incidents and adverse events must be recorded, managed, and stored accurately for communication, verification, and interpretation.

Usage Errors and Abnormal Uses: Errors in use must be evaluated by the health record holder, and incidents due to abnormal use should not be reported. Clinical research units, establishments selling medical devices, and users all have specific roles in the reporting process.

Handling Incidents: The handling of incidents due to abnormal use involves investigation and collaboration with the manufacturer. Various sources of information, including post-marketing studies and international health authorities, contribute to risk assessments.

Access to Medical Devices: Access to the medical device involved in an adverse incident is crucial for thorough investigations, and the user may be consulted for additional information.

Investigating Adverse Incidents: Before communicating adverse events to the community, the health record holder or legal representative must conduct a corresponding investigation to evaluate the incident thoroughly.

The CNFV is responsible for proposing policies, programs, and procedures for technovigilance in Mexico. The medical device vigilance reporting is carried out through various notifications and reports, and state and institutional centers must have designated leaders and coordinators for these activities.

Notification Process of medical device adverse events

The notification process involves detailed reporting, including data on the person presenting the notification, company details, patient information, details of the adverse incident, and identification of the medical device. 

Criteria for Reporting Adverse Incidents

Incidents meeting criteria related to occurrence, relation to the medical device, and outcomes such as death or serious deterioration in health must be reported to the CNFV. The criteria for determining which adverse events should be reported to the National Pharmacovigilance Center (CNFV) in Mexico are outlined in three key criteria:

Criteria for Reporting Adverse Incidents

Any adverse incident meeting these three criteria must be reported to the CNFV. These criteria comprehensively cover incidents ranging from device malfunctions to those with severe outcomes, ensuring a thorough and systematic approach to technovigilance in Mexico.

Exceptions to Notification of Adverse Incidents

In certain circumstances, the holder of the health registration of a medical device or its legal representative in Mexico may be exempt from reporting certain incidents. The exceptions to notification are detailed as follows:

User-Identified Malfunctions:  Incidents where a user identifies a malfunction or deterioration in the medical device before use need not be reported.

Patient Medical Condition: If the incident is attributed to a pre-existing or occurring medical condition of the patient during device use, notification is not required. Justification requires information confirming that the device functioned as intended without contributing to user death or serious health deterioration.

Expired Useful Life: Incidents involving the use of medical devices beyond their specified useful life, as per the health registration holder's instructions, do not require reporting.

Functioning Alarm or Failsafe System: Correctly functioning alarm or failsafe systems preventing severe health deterioration or death do not necessitate notification.

Low Probability, Low-Frequency Incidents: Incidents with a low probability and low frequency of causing harm, documented by the manufacturer as acceptable after risk assessment, need not be reported.

Planned Adverse Incidents: Planned adverse incidents clearly identified in device documentation or known clinically as foreseeable, with qualitative and quantitative predictability, and documented in the device master file with a pre-incident risk assessment, are exempt. Additionally, planned incidents must be clinically acceptable in terms of patient benefit.

Post-Warning Notice Incidents: No Separate Notification Required for Incidents occurring after a manufacturer's warning notice publication, with the same fundamental cause as specified in the notice, do not require separate notification if covered in the initial notice. This includes product recall, corrective action, and product return instructions.

CNFV-Granted Exceptions: The CNFV may grant exceptions to notification requirements upon the request of the health registration holder or its legal representative in Mexico.

These exceptions provide a nuanced framework, ensuring that certain incidents with well-defined characteristics, low risks, or pre-determined clinical acceptability may be exempt from mandatory reporting to the CNFV.

The timelines for notification depend on the severity of the incident.

Post-Warning Notice Incidents:

* If necessary, the holder of the health record has the option to request an extension, which should not exceed the duration of the initial period.

Technovigilance in Mexico is a dynamic and comprehensive process aimed at ensuring the safety and effectiveness of medical devices. Adherence to regulatory guidelines, timely reporting of adverse incidents, and collaboration between stakeholders are crucial elements in this system. By navigating these regulations effectively, stakeholders contribute to maintaining high standards of healthcare and safeguarding public health.

In navigating the intricate landscape of technovigilance in Mexico, Artixio stands as your dedicated partner in ensuring compliance, efficiency, and excellence in managing adverse incidents related to medical devices.

As experts in regulatory intelligence and compliance solutions, Artixio is poised to assist you in seamlessly navigating the technovigilance process.

Have questions or need assistance in implementing robust technovigilance practices?

Contact Artixio today for personalized guidance, compliance support, and innovative solutions tailored to your unique needs. Your journey to enhanced technovigilance begins with a simple step – reach out to Artixio and empower your approach to healthcare safety.

Your commitment to technovigilance excellence starts here with Artixio.


bottom of page